Shilpa Medicare · NSE: SHILPAMED · BSE: 530549

Q1 FY24 results · Apr–Jun 2023

Shilpa Medicare reported revenue from operations of ₹260.17 crore (down 0.4% from Q1 FY23) and net profit of ₹1.18 crore (down 49.8% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY24Q1 FY23YoYQ4 FY23QoQ
Revenue from operations260.17261.16−0.4%263.56−1.3%
Other income1.938.10−76.2%2.17−11.1%
Total income262.11269.26−2.7%265.73−1.4%
Profit before share of associates & JVs and tax4.95(3.34)Turned profit(3.03)Turned profit
Share of profit/(loss) of associates & JVs(1.66)(0.73)(1.19)
Net profit for the period1.182.34−49.8%(8.04)Turned profit
EPS, basic (₹)0.140.10+40.0%(0.93)Turned profit
Net margin (%)0.50.9-3.1

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ1 FY24Q1 FY23YoYQ4 FY23QoQ
Revenue from operations83.7460.83+37.7%66.50+25.9%
Other income20.7812.63+64.6%20.33+2.2%
Total income104.5273.46+42.3%86.83+20.4%
Profit before tax10.764.05+165.7%(26.99)Turned profit
Net profit for the period7.90108.08−92.7%(28.93)Turned profit
EPS, basic (₹)0.9112.45−92.7%(3.33)Turned profit
Net margin (%)9.4177.7-43.5
Consolidated
Filed with BSE
10 Aug 2023, 19:18 IST
Board meeting
10 Aug 2023
Period
01 Apr 2023 to 30 Jun 2023
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
10 Aug 2023, 19:18 IST
Board meeting
10 Aug 2023
Period
01 Apr 2023 to 30 Jun 2023
Review status
Unaudited
Source
XBRL filing on BSE